Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-10 21:43:08 UTC |
---|
Update Date | 2021-09-26 22:52:23 UTC |
---|
HMDB ID | HMDB0244569 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one |
---|
Description | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one belongs to the class of organic compounds known as tryptamines and derivatives. Tryptamines and derivatives are compounds containing the tryptamine backbone, which is structurally characterized by an indole ring substituted at the 3-position by an ethanamine. Based on a literature review very few articles have been published on (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one. This compound has been identified in human blood as reported by (PMID: 31557052 ). (4r)-4-[[3-(2-dimethylaminoethyl)-1h-indol-5-yl]methyl]oxazolidin-2-one is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CN(C)CCC1=CNC2=C1C=C(CC1COC(=O)N1)C=C2 InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20) |
---|
Synonyms | Not Available |
---|
Chemical Formula | C16H21N3O2 |
---|
Average Molecular Weight | 287.363 |
---|
Monoisotopic Molecular Weight | 287.163376928 |
---|
IUPAC Name | 4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one |
---|
Traditional Name | 4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one |
---|
CAS Registry Number | Not Available |
---|
SMILES | CN(C)CCC1=CNC2=C1C=C(CC1COC(=O)N1)C=C2 |
---|
InChI Identifier | InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20) |
---|
InChI Key | ULSDMUVEXKOYBU-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as tryptamines and derivatives. Tryptamines and derivatives are compounds containing the tryptamine backbone, which is structurally characterized by an indole ring substituted at the 3-position by an ethanamine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Indoles and derivatives |
---|
Sub Class | Tryptamines and derivatives |
---|
Direct Parent | Tryptamines and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Tryptamine
- 3-alkylindole
- Indole
- Aralkylamine
- Oxazolidinone
- Substituted pyrrole
- Benzenoid
- Oxazolidine
- Pyrrole
- Heteroaromatic compound
- Carbamic acid ester
- Carbonic acid derivative
- Tertiary amine
- Tertiary aliphatic amine
- Oxacycle
- Azacycle
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Carbonyl group
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
(4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,1TMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C)C2=CC=C(CC3COC(=O)N3)C=C12 | 2762.9 | Semi standard non polar | 33892256 | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,1TMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C)C2=CC=C(CC3COC(=O)N3)C=C12 | 2774.2 | Standard non polar | 33892256 | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,1TMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C)C2=CC=C(CC3COC(=O)N3)C=C12 | 3985.4 | Standard polar | 33892256 | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,1TMS,isomer #2 | CN(C)CCC1=C[NH]C2=CC=C(CC3COC(=O)N3[Si](C)(C)C)C=C12 | 2710.3 | Semi standard non polar | 33892256 | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,1TMS,isomer #2 | CN(C)CCC1=C[NH]C2=CC=C(CC3COC(=O)N3[Si](C)(C)C)C=C12 | 2738.5 | Standard non polar | 33892256 | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,1TMS,isomer #2 | CN(C)CCC1=C[NH]C2=CC=C(CC3COC(=O)N3[Si](C)(C)C)C=C12 | 3496.0 | Standard polar | 33892256 | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,2TMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C)C2=CC=C(CC3COC(=O)N3[Si](C)(C)C)C=C12 | 2709.2 | Semi standard non polar | 33892256 | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,2TMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C)C2=CC=C(CC3COC(=O)N3[Si](C)(C)C)C=C12 | 2761.5 | Standard non polar | 33892256 | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,2TMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C)C2=CC=C(CC3COC(=O)N3[Si](C)(C)C)C=C12 | 3246.3 | Standard polar | 33892256 | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,1TBDMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=C(CC3COC(=O)N3)C=C12 | 2976.1 | Semi standard non polar | 33892256 | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,1TBDMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=C(CC3COC(=O)N3)C=C12 | 2981.0 | Standard non polar | 33892256 | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,1TBDMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=C(CC3COC(=O)N3)C=C12 | 3975.4 | Standard polar | 33892256 | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,1TBDMS,isomer #2 | CN(C)CCC1=C[NH]C2=CC=C(CC3COC(=O)N3[Si](C)(C)C(C)(C)C)C=C12 | 2924.2 | Semi standard non polar | 33892256 | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,1TBDMS,isomer #2 | CN(C)CCC1=C[NH]C2=CC=C(CC3COC(=O)N3[Si](C)(C)C(C)(C)C)C=C12 | 2965.7 | Standard non polar | 33892256 | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,1TBDMS,isomer #2 | CN(C)CCC1=C[NH]C2=CC=C(CC3COC(=O)N3[Si](C)(C)C(C)(C)C)C=C12 | 3555.2 | Standard polar | 33892256 | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,2TBDMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=C(CC3COC(=O)N3[Si](C)(C)C(C)(C)C)C=C12 | 3117.2 | Semi standard non polar | 33892256 | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,2TBDMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=C(CC3COC(=O)N3[Si](C)(C)C(C)(C)C)C=C12 | 3175.6 | Standard non polar | 33892256 | (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,2TBDMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=C(CC3COC(=O)N3[Si](C)(C)C(C)(C)C)C=C12 | 3354.6 | Standard polar | 33892256 |
| Show more...
---|